Patient-reported outcomes as non-muscle-invasive bladder cancer clinical trial endpoints.
OBJECTIVE To evaluate the frequency at which patient-reported outcomes (PROs) are incorporated as nonmuscle-invasive bladder cancer (NMIBC) clinical trial endpoints. PATIENTS AND METHODS Interventional trials limited to patients with NMIBC were queried from clinicaltrials.gov from 1994 to 2025 (start of trial). Obser...